Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas

Virchows Archiv

Volumn 452, Issue 5, 2008, Pages 525-534

  Zheng, Hua Chuan ^a,b   Li, Xiao Han ^a,b   Hara, Takuo ^c   Masuda, Shinji ^c   Yang, Xiang Hong ^a   Guan, Yi Fu ^a   Takano, Yasuo ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TOYAMA   (Japan)

^c KOUSEIREN TAKAOKA HOSPITAL   (Japan)

Author keywords

Carcinogenesis; Gastric carcinoma; Lauren's classification; Mixed type; Pathobiological behaviors

Indexed keywords

BETA CATENIN; CASPASE 3; CD147 ANTIGEN; FRAGILE HISTIDINE TRIAD PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; HERMES ANTIGEN; KI 67 ANTIGEN; MASPIN; MUCIN 2; MUCIN 4; MUCIN 5AC; MUCIN 6; PROTEIN P53; UVOMORULIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL ADHESION; CLINICAL FEATURE; FEMALE; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL ADHESION; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MIXED TUMOR, MALIGNANT; NEOPLASM INVASIVENESS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 42549115809     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0572-7     Document Type: Article

References (36)

1. Ali A, Hoeflich KP, Woodgett JR (2001) Glycogen synthase kinase-3: properties, functions, and regulation. Chem Rev 101:2527-2540
2. Borch K, Jonsson B, Tarpila E, Franzen T, Berglund J, Kullman E, Franzen L (2000) Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma. Br J Surg 87:618-626
3. Byrd JC, Bresalier RS (2004) Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 23:77-99
4. Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, Caldas C, Sobrinho-Simões M (2004) Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 203:681-687
5. Carneiro F, Seixas M, Sobrinho-Simoes M (1995) New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 191:571-584
6. Esaki Y, Hirayama R, Hirokawa K (1990) A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer 65:2086-2090
7. Hamilton SR, Aaltonen LA (eds) (2000) In: WHO classification of tumors: pathology and genetics of tumors of the digestive system. IARC, Lyon, pp 39-50
8. Hong RL, Lee WJ, Shun CT, Chu JS, Chen YC (1995) Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas. Oncology 52:334-339
9. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC (2004) Gastric cancer originating from bone marrow-derived cells. Science 306:1568-1571
10. Huang SP, Wu MS, Wang HP, Yang CS, Kuo ML, Lin JT (2002) Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma. J Gastroenterol Hepatol 17:1165-1169
11. Kelley JR, Duggan JM (2003) Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56:1-9
12. Kushima R, Hattori T (1993) Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J Cancer Res Clin Oncol 120:103-111
13. Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K, Hattori T (2006) Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer 9:177-184
14. Kozuki T, Yao T, Nakamura S, Matsumoto T, Tsuneyoshi M (2002) Differences in p53 and cadherin-catenin complex expression between histological subtypes in diffusely infiltrating gastric carcinoma. Histopathology 41:56-64
15. Kumada T, Tsuneyama K, Hatta H, Ishizawa S, Takano Y (2004) Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol 17:1141-1149
16. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31-49
17. Li HC, Stoicov C, Rogers AB, Houghton J (2006) Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 12:363-371
18. Liu SC (1989) A newly recognized precancerous lesion of the stomach-histopathologic features of globoid dysplasia of human gastric epithelium. Zhonghua Zhong Liu Za Zhi 11:37-40
19. Lynch HT, Grady W, Suriano G, Huntsman D (2005) Gastric cancer: new genetic developments. J Surg Oncol 90:114-133
20. Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simões M (2000) Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 190:437-43
21. Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N, Berx G, Sobrinho-Simoes M (1999) E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 79:459-465
22. Reis CA, David L, Nielsen PA, Clausen H, Mirgorodskaya K, Roepstorff P, Sobrinho-Simões M (1997) Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 74:112-121
23. Roukos DH, Agnantis NJ, Fatouros M, Kappas AM (2002) Gastric cancer: introduction, pathology, epidemiology. Gastric & Breast Cancer 1:1-3
24. Shibata A, Longacre TA, Puligandla B, Parsonnet J, Habel LA (2001) Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists. Cancer Epidemiol Biomarkers Prev 10:75-78
25. Sobin LH, Wittekind CH (2002) TNM classification of malignant tumors, 6th edn. John Wiley, New York, pp 55-65
26. Stelzner S, Emmrich P (1997) The mixed type in Lauren's classification of gastric carcinoma. Histologic description and biologic behavior. Gen Diagn Pathol 143:39-48
27. Tahara E (2004) Genetic pathways of two types of gastric cancer. IARC Sci Publ 157:327-349
28. Zheng HC, Sun JM, Wei ZL, Yang XF, Zhang YC, Xin Y (2003) Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer. World J Gastroenterol 9:1415-1420
29. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K, Takano Y (2006a) Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26:3579-3583
30. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, Tsuneyama K, Takano Y (2007a) Pathobiological characteristics of intestinal- and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol 60:273-277
31. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Tsuneyama K, Masuda S, Takano Y (2007b) Low expression of FHIT and PTEN correlates with malignancy of gastric carcinoma: tissue-array findings. Appl Immunohistochem Mol Morphol 15(4):432-440
32. Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K, Takano Y (2006d) Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 95:1371-1378
33. Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K, Takano Y (2006b) MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol 132:817-823
34. Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K, Takano Y (2006c) An immunohistochemical study of p53 and Ki-67 in gastrointestinal adenoma and adenocarcinoma using tissue microarray. Anticancer Res 26:2353-2360
35. Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K, Takano Y (2007c) Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res 27:259-265
36. Zheng L, Wang L, Ajani J, Xie K (2004) Molecular basis of gastric cancer development and progression. Gastric Cancer 7:61-77